Abstract
The purpose of this study is to summarize evidence for the use of adipose stem cell (ASC) injections in the treatment of rotator cuff tears (RCT) and identify future areas of study. A thorough literature search was performed to identify studies investigating the use of ASC injections in the treatment of RCTs. Among animal trials, it is unclear whether ASCs are of benefit for rotator cuff repair. In clinical trials, ASC injection may reduce retear rate with otherwise equivocal clinical outcomes. Although ASC injection may be safe, the literature does not provide a clear consensus as to the efficacy of ASC injections, nor does it delineate which patients would benefit most from this treatment.
Plain language summary
The purpose of this paper is to review available studies that look at the effects of adipose stem cell (ASC) injections in the treatment of rotator cuff tears (RCT). A thorough literature search of all available studies was performed. Among lab studies in animals, it is unclear if ASCs help improve the outcomes of rotator cuff repair. In studies using live patients, ASC injection may reduce retear rate, but it is unclear whether there are any other benefits to ASC injection. ASC injection is safe in humans, but the literature does not provide a clear consensus as to how much benefit this treatment provides for rotator cuff repair, nor does it delineate which patients would benefit most from this treatment.
Graphical abstract
Papers of special note have been highlighted as: • of interest
References
- 1. Natural course of nontraumatic rotator cuff tendinitis and shoulder symptoms in a working population. Scand. J. Work Environ. Health 32(2), 99–108 (2006).
- 2. Estimating the burden of musculoskeletal disorders in the community: the comparative prevalence of symptoms at different anatomical sites, and the relation to social deprivation. Ann. Rheum. Dis. 57(11), 649–655 (1998).
- 3. Prevalence of symptomatic and asymptomatic rotator cuff tears in the general population: from mass-screening in one village. J. Orthop. 10(1), 8–12 (2013).
- 4. . Management of rotator cuff Injuries. J. Am. Acad. Orthop. Surg. 28(5), e193–e201 (2020).
- 5. . Arthroscopic rotator cuff repair: magnetic resonance arthrogram assessment of tendon healing. J. Shoulder Elbow Surg. 28(11), 2161–2170 (2019).
- 6. Minimum 10-year outcomes of primary arthroscopic transosseous-equivalent double-row rotator cuff repair. Am. J. Sports Med. 49(8), 2035–2041 (2021).
- 7. . Does bicep pathology affect rotator cuff repair outcomes? J. Orthop. Surg. (Hong Kong) 26(1), 2309499018762852 (2018).
- 8. . Which method of rotator cuff repair leads to the highest rate of structural healing? A systematic review. Am. J. Sports Med. 38(4), 835–841 (2010).
- 9. Risk factors for retear of large/massive rotator cuff tears after arthroscopic surgery: an analysis of tearing patterns. J. Orthop. Surg. Res. 12(1), 140 (2017).
- 10. The effect of platelet-rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. Am. J. Sports Med. 40(6), 1234–1241 (2012).
- 11. Rotator cuff repair with autologous tenocytes and biodegradable collagen scaffold: a histological and biomechanical study in sheep. Am. J. Sports Med. 48(2), 450–459 (2020).
- 12. Biomechanical analysis of an ovine rotator cuff repair via porous patch augmentation in a chronic rupture model. Am. J. Sports Med. 38(4), 679–686 (2010).
- 13. . Scaffold devices for rotator cuff repair. J. Shoulder Elbow Surg. 21(2), 251–265 (2012).
- 14. Rotator cuff repair with biological graft augmentation causes adverse tissue outcomes. Acta Orthop. 91(6), 782–788 (2020).
- 15. . Expression of insulin-like growth factor type 1 receptor and myosin heavy chain in rabbit's rotator cuff muscle after injection of adipose-derived stem cell. Knee Surg. Sports Traumatol. Arthrosc 22(11), 2867–2873 (2014).
- 16. . Adipose-derived stem cells improve tendon repair and prevent ectopic ossification in tendinopathy by inhibiting inflammation and inducing neovascularization in the early stage of tendon healing. Regen. Ther. 14, 103–110 (2020).
- 17. . Concise review: adipose-derived stem cells as a novel tool for future regenerative medicine. Stem Cells 30(5), 804–810 (2012).
- 18. Tenogenically differentiated adipose-derived stem cells are effective in Achilles tendon repair in vivo. J. Tissue Eng. 9, 2041731418811183 (2018).
- 19. . Adipose-derived mesenchymal stem cells: biology and potential applications. Adv. Biochem. Eng. Biotechnol. 129, 59–71 (2013).
- 20. Extracellular vesicles of adipose-derived stem cells promote the healing of traumatized Achilles tendons. Int. J. Mol. Sci. 22(22), 2–12 (2021).
- 21. Tenomodulin knockout mice exhibit worse late healing outcomes with augmented trauma-induced heterotopic ossification of Achilles tendon. Cell Death Dis. 12(11), 1049 (2021).
- 22. . Tenomodulin is necessary for tenocyte proliferation and tendon maturation. Mol Cell Biol 25(2), 699–705 (2005).
- 23. . Tenomodulin is essential for prevention of adipocyte accumulation and fibrovascular scar formation during early tendon healing. Cell Death Dis. 8(10), e3116 (2017).
- 24. The tendon injury response is influenced by decorin and biglycan. Ann. Biomed. Eng. 42(3), 619–630 (2014).
- 25. Administration of adipose-derived stem cells enhances vascularity, induces collagen deposition, and dermal adipogenesis in burn wounds. Burns 42(6), 1212–1222 (2016).
- 26. Enhanced wound vascularization using a dsASCs seeded FPEG scaffold. Angiogenesis 16(4), 745–757 (2013).
- 27. . Biological roles of hepatocyte growth factor-Met signaling from genetically modified animals. Biomed. Rep. 7(6), 495–503 (2017).
- 28. Use of adipose-derived stem cells in an experimental rotator cuff fracture animal model [in Spanish]. Rev. Esp. Cir. Ortop. Traumatol. 59(1), 3–8 (2015).
- 29. Human adipose-derived stem cells accelerate the restoration of tensile strength of tendon and alleviate the progression of rotator cuff injury in a rat model. Cell Transplant. 24(3), 509–520 (2015).
- 30. Augmentation of chronic rotator cuff healing using adipose-derived stem cell-seeded human tendon-derived hydrogel. J. Orthop. Res. 37(4), 877–886 (2019).
- 31. . Beige FAPs Transplantation Improves Muscle Quality and Shoulder Function After Massive Rotator Cuff Tears. J. Orthop. Res. 38(5), 1159–1166 (2020).
- 32. . Magnetic resonance imaging and biomechanical analysis of adipose-derived stromal vascular fraction applied on rotator cuff repair in rabbits. Chin. Med. J. (Engl). 131(1), 69–74 (2018).
- 33. Effects of local application of adipose-derived stromal vascular fraction on tendon-bone healing after rotator cuff tear in rabbits. Chin. Med. J. (Engl). 131(21), 2620–2622 (2018). • Rabbit randomized basic science study examining effects of adipose stem cell (ASC) injection on suture repair of rotator cuff tears. In support of ASCs.
- 34. 2013 Neer Award: effect of the adipose-derived stem cell for the improvement of fatty degeneration and rotator cuff healing in rabbit model. J. Shoulder Elbow Surg. 23(4), 445–455 (2014). • Rabbit randomized basic science study examining effects of ASC injection on suture repair of rotator cuff tears. Does not support use of ASCs.
- 35. The effect of adipose-derived stem cells on enthesis healing after repair of acute and chronic massive rotator cuff tears in rats. J. Shoulder Elbow Surg. 28(4), 654–664 (2019). • Rat randomized basic science study examining chronicity of RCTs and how augmentation of repair with ASCs impacts outcomes. Does not support use of ASCs.
- 36. Application of adipose tissue-derived stem cells in a rat rotator cuff repair model. Injury 45(Suppl. 4), S22–27 (2014).
- 37. et al. Exosomes isolated from adipose-derived stem cells: a new cell-free approach to prevent the muscle degeneration associated with torn rotator cuffs. Am. J. Sports Med. 47(13), 3247–3255 (2019). • Rat randomized basic science study using surgical model. Supports use of ASCs.
- 38. et al. Adipose stem cell-derived exosomes decrease fatty infiltration and enhance rotator cuff healing in a rabbit model of chronic tears. Am. J. Sports Med. 48(6), 1456–1464 (2020). • Rat randomized basic science study non-surgical model. Supports use of ASCs.
- 39. Efficient in vivo bone formation by BMP-2 engineered human mesenchymal stem cells encapsulated in a projection stereolithographically fabricated hydrogel scaffold. Stem Cell Res. Ther. 10(1), 254 (2019).
- 40. The effect of adipose-derived mesenchymal stem cells on healing of massive chronic rotator cuff tear in rodent model. Orthopaed. J. Sports Med. 5(7 Suppl. 6), 2325967117S2325900375 (2017).
- 41. Adipose tissue as a stem cell source for musculoskeletal regeneration. Front Biosci. (Schol. Ed.). 3(1), 69–81 (2011).
- 42. . Immunomodulatory effects of adipose-derived stem cells: fact or fiction? Biomed. Res. Int. 2013, 383685 (2013).
- 43. Adipose tissue-derived mesenchymal stem cells increase skin allograft survival and inhibit Th-17 immune response. PLoS One 8(10), e76396 (2013).
- 44. . Management of complications after rotator cuff surgery. Curr. Rev, Musculoskelet. Med. 8(1), 40–52 (2015).
- 45. . Functional anatomy of the head-neck movement system of quadrupedal and bipedal mammals. J. Anat. 186(Pt 1), 55–74 (1995).
- 46. . The role of animal models in tendon research. Bone Joint Res. 3(6), 193–202 (2014).
- 47. Animal models for rotator cuff repair. Ann. N. Y. Acad. Sci. 1383(1), 43–57 (2016).
- 48. et al. Rotator cuff repair: a review of surgical techniques, animal models, and new technologies under development. J. Shoulder Elbow Surg. 25(12), 2078–2085 (2016).
- 49. . Assessment of the canine model of rotator cuff injury and repair. J. Shoulder Elbow Surg. 16(Suppl. 5), S140–148 (2007).
- 50. . Preclinical models for translating regenerative medicine therapies for rotator cuff repair. Tissue Eng. Part B Rev. 16(1), 21–30 (2010).
- 51. Safety and efficacy of treating symptomatic, partial-thickness rotator cuff tears with fresh, uncultured, unmodified, autologous adipose-derived regenerative cells (UA-ADRCs) isolated at the point of care: a prospective, randomized, controlled first-in-human pilot study. J. Orthop Surg. Res. 15(1), 122 (2020). • Comparison of ASC injection to corticosteroid injection, nonsurgical.
- 52. Intratendinous injection of mesenchymal stem cells for the treatment of rotator cuff disease: a 2-year follow-up study. Arthroscopy 36(4), 971–980 (2020). • Very small patient population, no control group, non-surgical.
- 53. et al. Does an injection of adipose-derived mesenchymal stem cells loaded in fibrin glue influence rotator cuff repair outcomes? A clinical and magnetic resonance imaging study. Am. J. Sports Med. 45(9), 2010–2018 (2017). • Largest patient population of all clinical trials to date. Surgical.
- 54. Intratendinous injection of autologous adipose tissue-derived mesenchymal stem cells for the treatment of rotator cuff disease: a first-in-human trial. Stem Cells 36(9), 1441–1450 (2018).
- 55. The role of vascular endothelial growth factor in wound healing. J. Surg. Res. 153(2), 347–358 (2009).
- 56. Red blood cells inhibit proliferation and stimulate apoptosis in human lung fibroblasts in vitro. Scand. J. Immunol. 59(6), 559–565 (2004).
- 57. Serum stem cell growth factor for monitoring hematopoietic recovery following stem cell transplantation. Bone Marrow Transplant. 32(4), 391–398 (2003).
- 58. . Red blood cells are dynamic reservoirs of cytokines. Sci. Rep. 8(1), 3101 (2018).
- 59. Red blood cells exposed to cancer cells in culture have altered cytokine profiles and immune function. Sci Rep 10(1), 7727 (2020).
- 60. Role of PDGF-BB in proliferation, differentiation and maintaining stem cell properties of PDL cells in vitro. Arch. Oral Biol. 85, 1–9 (2018).
- 61. . Critical role of transforming growth factor beta in different phases of wound healing. Adv. Wound Care (New Rochelle) 2(5), 215–224 (2013).
- 62. . Colony forming unit assays for MSCs. Methods Mol. Biol. 449, 83–91 (2008).
- 63. Serum stem cell growth factor beta for the prediction of therapy response in hepatocellular carcinoma. Biomed. Res. Int. 2018, 6435482 (2018).
- 64. Collagen gel contraction as a measure of fibroblast function in carpal tunnel syndrome. J. Biomed. Mater. Res. A 103(2), 574–580 (2015).
- 65. Effect of vascular endothelial growth factor on rat Achilles tendon healing. Plast. Reconstr. Surg. 112(6), 1613–1619 (2003).
- 66. Use of adipose-derived stem cells in an experimental rotator cuff fracture animal model. Rev. Esp. Cir. Ortop. Traumatol. 59(1), 3–8 (2015).
- 67. Application of adipose tissue-derived stem cells in a rat rotator cuff repair model. Injury 45(Suppl. 4), S22–27 (2014).
- 68. Reduced levels of mesenchymal stem cells at the tendon-bone interface tuberosity in patients with symptomatic rotator cuff tear. Int. Orthop. 39(6), 1219–1225 (2015).
- 69. . Adipose tissue – adequate, accessible regenerative material. Int. J. Stem Cells 8(2), 121–127 (2015).
- 70. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7(2), 211–228 (2001).